title: Amifostine and 2-CdA: a novel purging strategy in CML autografting?
authors.forename: A
authors.initials: A
authors.lastname: Korycka
authors.forename: T
authors.initials: T
authors.lastname: Robak
mesh_terms: D000328:Adult; D000368:Aged; D004999:Amifostine / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016465:Bone Marrow Purging / Q000379:methods; D017338:Cladribine / Q000627:therapeutic use; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D008875:Middle Aged; D009368:Neoplasm Transplantation; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D011837:Radiation-Protective Agents; D017338:Cladribine; D004999:Amifostine